IL6 and COVID-19: Our findings indicated that patients with severe COVID-19 who progress to ICU admission and/or death are characterized by a markedly disturbed IR, mainly involving elevated serum levels of IL6, IL15, sIL1RII, sRAGE, IP10 and MCP3 in the first week of hospitalization.